[1] |
Cao Y, Jiang SY, Sun JH, et al. Assessment of neonatal intensive care unit practices, morbidity, and mortality among very preterm infants in China[J]. JAMA Netw Open, 2021, 4(8): e2118904. DOI: 10.1001/jamanetworkopen.2021.18904.
|
[2] |
Costa LR P, Costa GAM, Valete COS, et al. In-hospital outcomes in preterm and small-for-gestational-age newborns: a cohort study[J]. Einstein (Sao Paulo), 2022, 20: eAO6781. DOI: 10.31744/einstein_journal/2022AO6781.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
Chiang MF, Quinn GE, Fielder AR, et al. International classification of retinopathy of prematurity, third edition[J]. Ophthalmology, 2021, 128(10): e51-e68. DOI: 10.1016/j.ophtha.2021.05.031.
|
[7] |
|
[8] |
Rhoads E, Montgomery GS, Ren CL. Wheezing in preterm infants and children[J]. Pediatr Pulmonol, 2021, 56(11): 3472-3477. DOI: 10.1002/ppul.25314.
|
[9] |
Wozniak P, Botros M, Diaz P. Pulmonary function testing and imaging studies among adult survivors of bronchopulmonary dysplasia[J]. Chest, 2022, 161(6): A459. DOI: 10.1016/j.chest.2021.12.489.
|
[10] |
Karatza AA, Gkentzi D, Varvarigou A. Nutrition of infants with bronchopulmonary dysplasia before and after discharge from the neonatal intensive care unit[J]. Nutrients, 2022, 14(16): 3311. DOI: 10.3390/nu14163311.
|
[11] |
Sucasas Alonso A, Pértega Diaz S, Sáez Soto R, et al. Epidemiology and risk factors for bronchopulmonary dysplasia in preterm infants born at or less than 32 weeks of gestation[J]. An Pediatr, 2022, 96(3): 242-251. DOI: 10.1016/j.anpede.2021.03.006.
|
[12] |
|
[13] |
|
[14] |
Yang K, He SS, Dong WB. Gut microbiota and bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 2021, 56(8): 2460-2470. DOI: 10.1002/ppul.25508.
|
[15] |
Sweet DG, Carnielli VP, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update[J]. Neonatology, 2023, 120(1): 3-23. DOI: 10.1159/000528914.
|
[16] |
|
[17] |
Tang L, Zhu TT, Zhao J. Association between red blood cell transfusion and bronchopulmonary dysplasia: a systematic review and Meta-analysis[J]. Front Pediatr, 2023, 11: 1095889. DOI: 10.3389/fped.2023.1095889.
|
[18] |
Bahr TM, Snow GL, Christensen TR, et al. Can red blood cell and platelet transfusions have a pathogenic role in bronchopulmonary dysplasia?[J]. J Pediatr, 2024, 265: 113836. DOI: 10.1016/j.jpeds.2023.113836
|
[19] |
Lapcharoensap W, Kan P, Powers RJ, et al. The relationship of nosocomial infection reduction to changes in neonatal intensive care unit rates of bronchopulmonary dysplasia[J]. J Pediatr, 2017, 180: 105-109.e1. DOI: 10.1016/j.jpeds.2016.09.030.
|
[20] |
Shah J, Jefferies AL, Yoon EW, et al. Risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at<32 weeks′ gestation[J]. Am J Perinatol, 2015, 32(7): 675-682. DOI: 10.1055/s-0034-1393936.
|
[21] |
Clyman RI, Kaempf J, Liebowitz M, et al. Prolonged tracheal intubation and the association between patent ductus arteriosus and bronchopulmonary dysplasia: a secondary analysis of the PDA-TOLERATE trial[J]. J Pediatr, 2021, 229: 283-288.e2. DOI: 10.1016/j.jpeds.2020.09.047.
|
[22] |
Vayalthrikkovil S, Vorhies E, Stritzke A, et al. Prospective study of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia[J]. Pediatr Pulmonol, 2019, 54(2): 171-178. DOI: 10.1002/ppul.24211.
|
[23] |
Al-Ghanem G, Shah P, Thomas S, et al. Bronchopulmonary dysplasia and pulmonary hypertension: a Meta-analysis[J]. J Perinatol, 2017, 37(4): 414-419. DOI: 10.1038/jp.2016.250.
|